Filing Details
- Accession Number:
- 0001225208-20-010436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-10 08:07:38
- Reporting Period:
- 2020-08-06
- Accepted Time:
- 2020-08-10 08:07:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1214686 | E Ronald Blaylock | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-06 | 4,000 | $38.49 | 4,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-06 | 3,000 | $38.55 | 7,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-06 | 2,500 | $38.56 | 9,500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-06 | 1,500 | $38.51 | 11,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-06 | 1,000 | $38.69 | 12,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-08-06 | 1,000 | $38.62 | 13,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |